These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19528134)

  • 1. Retention of under-represented minorities in drug abuse treatment studies.
    Magruder KM; Bichun Ouyang ; Miller S; Tilley BC
    Clin Trials; 2009 Jun; 6(3):252-60. PubMed ID: 19528134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addiction treatment trials: how gender, race/ethnicity, and age relate to ongoing participation and retention in clinical trials.
    Korte JE; Rosa CL; Wakim PG; Perl HI
    Subst Abuse Rehabil; 2011; 2():205-18. PubMed ID: 24474858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse treatment programs: a pooled analysis of two randomized controlled trials.
    Crits-Christoph P; Gallop R; Sadicario JS; Markell HM; Calsyn DA; Tang W; He H; Tu X; Woody G
    Subst Abuse Treat Prev Policy; 2014 Jan; 9():3. PubMed ID: 24433412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of readiness for drug abuse treatment on client retention and assessment of process.
    Joe GW; Simpson DD; Broome KM
    Addiction; 1998 Aug; 93(8):1177-90. PubMed ID: 9813899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing access and retention in substance abuse treatment: the role of Medicaid payment acceptance and cultural competence.
    Guerrero EG
    Drug Alcohol Depend; 2013 Oct; 132(3):555-61. PubMed ID: 23669458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivational enhancement therapy for African American substance users: a randomized clinical trial.
    Montgomery L; Burlew AK; Kosinski AS; Forcehimes AA
    Cultur Divers Ethnic Minor Psychol; 2011 Oct; 17(4):357-365. PubMed ID: 21988576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment and retention in obesity prevention and treatment trials targeting minority or low-income children: a review of the clinical trials registration database.
    Cui Z; Seburg EM; Sherwood NE; Faith MS; Ward DS
    Trials; 2015 Dec; 16():564. PubMed ID: 26651822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical Effects of Religious Participation and Marriage on Substance Use and Abuse in Racial and Ethnic Minorities.
    Hearld KR; Badham A; Budhwani H
    J Relig Health; 2017 Aug; 56(4):1155-1169. PubMed ID: 27900640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial/ethnic differences in unmet needs for mental health and substance use treatment in a community-based sample of sexual minority women.
    Jeong YM; Veldhuis CB; Aranda F; Hughes TL
    J Clin Nurs; 2016 Dec; 25(23-24):3557-3569. PubMed ID: 27461857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment.
    Schroder R; Sellman D; Frampton C; Deering D
    Drug Alcohol Rev; 2009 Nov; 28(6):663-8. PubMed ID: 19930021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Housing Status and Retention Rates among HIV-Positive African Americans Enrolled in a Comprehensive Care Program.
    Xiao H; Mains W
    J Psychoactive Drugs; 2016; 48(2):109-14. PubMed ID: 26960017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network.
    Burlew K; Larios S; Suarez-Morales L; Holmes B; Venner K; Chavez R
    Cultur Divers Ethnic Minor Psychol; 2011 Oct; 17(4):345-56. PubMed ID: 21988575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network.
    Burlew AK; Weekes JC; Montgomery L; Feaster DJ; Robbins MS; Rosa CL; Ruglass LM; Venner KL; Wu LT
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):324-32. PubMed ID: 21854274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Utilization Among Adolescent Substance Users: Findings from the 2002 to 2013 National Survey on Drug Use and Health.
    Haughwout SP; Harford TC; Castle IJ; Grant BF
    Alcohol Clin Exp Res; 2016 Aug; 40(8):1717-27. PubMed ID: 27427179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation and retention in drug abuse treatment services research.
    Vaughn T; Sarrazin MV; Saleh SS; Huber DL; Hall JA
    J Subst Abuse Treat; 2002 Dec; 23(4):387-97. PubMed ID: 12495801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.
    Satre DD; Mertens JR; Areán PA; Weisner C
    Addiction; 2004 Oct; 99(10):1286-97. PubMed ID: 15369567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug abuse treatment outcome study of adolescents: a comparison of client characteristics and pretreatment behaviors in three treatment modalities.
    Rounds-Bryant JL; Kristiansen PL; Hubbard RL
    Am J Drug Alcohol Abuse; 1999 Nov; 25(4):573-91. PubMed ID: 10548436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed and dynamic predictors of client retention in therapeutic communities.
    Condelli WS; De Leon G
    J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.